Wells Fargo & Company Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock

Lam Research (NASDAQ:LRCX) had its price target boosted by equities research analysts at Wells Fargo & Company from $250.00 to $290.00 in a research report issued on Thursday, MarketBeat reports. The firm currently has an “overweight” rating on the semiconductor company’s stock. Wells Fargo & Company‘s target price points to a potential upside of 24.22% from the company’s current price.

Several other research analysts have also issued reports on LRCX. Evercore ISI raised their target price on shares of Lam Research from $170.00 to $241.00 and gave the company an “outperform” rating in a research note on Monday, January 26th. Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 20th. Citigroup reiterated a “buy” rating and set a $265.00 target price (up previously from $190.00) on shares of Lam Research in a research report on Thursday, January 22nd. Barclays set a $250.00 price target on Lam Research in a research report on Thursday. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $238.32.

Lam Research Stock Down 5.9%

Shares of LRCX opened at $233.46 on Thursday. The business’s fifty day moving average price is $187.29 and its two-hundred day moving average price is $146.02. The firm has a market capitalization of $293.23 billion, a price-to-earnings ratio of 47.84, a PEG ratio of 3.05 and a beta of 1.77. Lam Research has a 52 week low of $56.32 and a 52 week high of $251.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.26.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.10. The business had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm’s revenue for the quarter was up 22.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 earnings per share. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, analysts predict that Lam Research will post 3.71 earnings per share for the current year.

Insider Activity

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 41,408 shares of company stock worth $6,248,501 in the last quarter. 0.31% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Lam Research

A number of large investors have recently added to or reduced their stakes in the business. PMV Capital Advisers LLC acquired a new position in shares of Lam Research in the fourth quarter valued at $25,000. IMG Wealth Management Inc. bought a new stake in shares of Lam Research during the 2nd quarter worth about $26,000. Stance Capital LLC acquired a new position in Lam Research in the 3rd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in Lam Research in the 2nd quarter valued at about $27,000. Finally, Triumph Capital Management bought a new position in Lam Research in the 3rd quarter valued at about $27,000. Institutional investors own 84.61% of the company’s stock.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Multiple major brokers sharply raised targets (many to $275–$300), signaling broad analyst bullishness after the quarter and suggesting upside versus earlier prices. These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results
• Positive Sentiment: JPMorgan and Citigroup raised targets to $300 (overweight/buy), and firms including Needham, TD Cowen, Wells Fargo, Deutsche and Stifel also lifted targets — a strong institutional vote of confidence for continued AI/foundry-driven demand. Analyst target increases (Benzinga)
• Positive Sentiment: Lam beat Q2 estimates (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B) and issued Q3 EPS guidance of $1.25–$1.45 and revenue above consensus — concrete operational drivers behind analyst upgrades. Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
• Neutral Sentiment: New Street Research raised its target to $235 but kept a neutral rating, reflecting near-term upside limited relative to recent price strength. New Street adjusts price target on Lam Research to $235
• Negative Sentiment: HSBC raised its target to $221 but maintained a “hold,” which implies downside from recent levels and highlights some analyst caution despite better results. HSBC adjusts price target on Lam Research to $221
• Negative Sentiment: Coverage notes flag valuation concerns after a large run (high P/E and steep analyst target dispersion), which may limit further upside and explains some profit‑taking. Lam Research Earnings Beat Highlights AI Demand But Raises Valuation Questions

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.